Long-Term Advantages of Fenfluramine for Lennox-Gastaut Syndrome

After originally receiving approval to treat seizures associated with Dravet syndrome in June 2020, the FDA recently approved fenfluramine (Fintepla; Zogenix) to include another rare childhood epileptic encephalopathy, Lennox-Gastaut syndrome (LGS).